Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Direxion S&P Biotech Bull 3X (LABU)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund basics

See More
  • Annual Dividend Yield 0.00%
  • Price/Earnings ttm 22.51
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
69.25 +27.20%
on 12/20/17
92.90 -5.18%
on 01/16/18
+18.88 (+27.27%)
since 12/19/17
3-Month
62.70 +40.49%
on 12/06/17
92.90 -5.18%
on 01/16/18
+5.45 (+6.59%)
since 10/19/17
52-Week
33.82 +160.46%
on 01/24/17
92.90 -5.18%
on 01/16/18
+49.83 (+130.23%)
since 01/19/17

Most Recent Stories

More News
The Zacks Analyst Blog Highlights: NAIL, CWEB, LABU, SOXL and EDC

The Zacks Analyst Blog Highlights: NAIL, CWEB, LABU, SOXL and EDC

NAIL : 106.93 (+3.07%)
EDC : 153.47 (+2.39%)
SOXL : 179.03 (+0.22%)
LABU : 88.10 (+3.26%)
CWEB : 62.65 (+1.10%)
7 Top-Performing Leveraged ETFs of 2017

The stock market bullishness has resulted in huge demand for leveraged ETFs as investors seek to register big gains in a short span.

NAIL : 106.93 (+3.07%)
KORU : 68.99 (+1.31%)
EDC : 153.47 (+2.39%)
SOXL : 179.03 (+0.22%)
LABU : 88.10 (+3.26%)
TECL : 133.14 (+0.38%)
CWEB : 62.65 (+1.10%)
7 Top-Performing Leveraged ETFs of 2017

The stock market bullishness has resulted in huge demand for leveraged ETFs as investors seek to register big gains in a short span.

NAIL : 106.93 (+3.07%)
KORU : 68.99 (+1.31%)
EDC : 153.47 (+2.39%)
SOXL : 179.03 (+0.22%)
LABU : 88.10 (+3.26%)
TECL : 133.14 (+0.38%)
CWEB : 62.65 (+1.10%)
New Pharma ETF PILL : What Investors Need to Know

Inside the pros and cons of the pharma sector and chances of outperformance of the just-launched fund PILL.

UBIO : 38.58 (+1.98%)
PJP : 68.65 (+0.65%)
VRTX : 157.92 (+0.46%)
CURE : 56.92 (+1.01%)
LABU : 88.10 (+3.26%)
GILD : 80.98 (-0.23%)
PILL : 32.80 (-0.06%)
New Pharma ETF PILL : What Investors Need to Know

Inside the pros and cons of the pharma sector and chances of outperformance of the just-launched fund PILL.

UBIO : 38.58 (+1.98%)
PJP : 68.65 (+0.65%)
VRTX : 157.92 (+0.46%)
CURE : 56.92 (+1.01%)
LABU : 88.10 (+3.26%)
GILD : 80.98 (-0.23%)
PILL : 32.80 (-0.06%)
Leveraged ETFs to Play the Second-Largest Bull Market

Braving all economic and political challenges, the U.S. stock market is scaling new highs, indicating that the second-largest bull run still has legs.

NAIL : 106.93 (+3.07%)
SOXL : 179.03 (+0.22%)
TQQQ : 168.21 (+0.86%)
CURE : 56.92 (+1.01%)
LABU : 88.10 (+3.26%)
TECL : 133.14 (+0.38%)
Leveraged ETFs to Play the Second-Largest Bull Market

Braving all economic and political challenges, the U.S. stock market is scaling new highs, indicating that the second-largest bull run still has legs.

NAIL : 106.93 (+3.07%)
SOXL : 179.03 (+0.22%)
TQQQ : 168.21 (+0.86%)
CURE : 56.92 (+1.01%)
LABU : 88.10 (+3.26%)
TECL : 133.14 (+0.38%)
Should You Keep Your Portfolio Healthy with Biotech ETFs?

Biotech ETFs are riding high on research and developments and FDA approvals.

BBC : 31.27 (+1.68%)
CNCR : 26.56 (+1.92%)
IBB : 112.01 (+0.67%)
VRTX : 157.92 (+0.46%)
BBH : 129.32 (+0.43%)
LABU : 88.10 (+3.26%)
K : 66.62 (+1.25%)
BBP : 41.29 (+1.43%)
SBIO : 34.83 (+1.72%)
UBIO : 38.58 (+1.98%)
CLVS : 56.75 (+1.58%)
BIB : 61.51 (+1.22%)
GILD : 80.98 (-0.23%)
SPY : 280.34 (+0.43%)
XBI : 88.90 (+1.15%)
Should You Keep Your Portfolio Healthy with Biotech ETFs?

Biotech ETFs are riding high on research and developments and FDA approvals.

BBC : 31.27 (+1.68%)
CNCR : 26.56 (+1.92%)
IBB : 112.01 (+0.67%)
VRTX : 157.92 (+0.46%)
BBH : 129.32 (+0.43%)
LABU : 88.10 (+3.26%)
K : 66.62 (+1.25%)
BBP : 41.29 (+1.43%)
SBIO : 34.83 (+1.72%)
UBIO : 38.58 (+1.98%)
CLVS : 56.75 (+1.58%)
BIB : 61.51 (+1.22%)
GILD : 80.98 (-0.23%)
SPY : 280.34 (+0.43%)
XBI : 88.90 (+1.15%)
The Zacks Analyst Blog Highlights: Direxion Daily S&P Biotech Bull 3X ETF, Direxion Daily South Korea Bull 3X ETF, Direxion Daily CSI China Internet Bull 2X Shares, Direxion Daily Hmbldrs&Supls Bull 3X ETF and Direxion Daily MSCI India Bull 3

The Zacks Analyst Blog Highlights: Direxion Daily S&P Biotech Bull 3X ETF, Direxion Daily South Korea Bull 3X ETF, Direxion Daily CSI China Internet Bull 2X Shares, Direxion Daily Hmbldrs&Supls Bull 3X...

NAIL : 106.93 (+3.07%)
KORU : 68.99 (+1.31%)
LABU : 88.10 (+3.26%)
CWEB : 62.65 (+1.10%)
INDL : 113.43 (+3.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

See More

Fund Summary

The Direxion Daily SP Biotech Bull 3x Shares seek daily investment results, before fees and expenses, of 300% or 300% of the inverse (or opposite) of the performance of the SP Biotechnology Select Industry Index. There is no guarantee the funds will meet their stated investment objectives.

See More

Top 10 Holdings

Name % Holdings
BANK OF NEW YORK CASH RESERVE 0.00%
DREYFUS GOVT CASH MGMT 0.00%
GOLDMAN FINL SQ TRSRY INST 506 0.00%
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP 0.00%
SPDR S&P BIOTECH ETF 0.00%

See More

Key Turning Points

2nd Resistance Point 89.35
1st Resistance Point 87.34
Last Price 88.10
1st Support Level 82.88
2nd Support Level 80.43

See More

52-Week High 92.90
Last Price 88.10
Fibonacci 61.8% 70.33
Fibonacci 50% 63.36
Fibonacci 38.2% 56.39
52-Week Low 33.82

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.